Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
10/23/26 Alphamab Oncology (9966) JSKN033 for Ovarian Cancer Subscribers Only Subscribers Only Subscribers Only
10/23/26 Alphamab Oncology (9966) JSKN033 for Uterine (Endometrial) Cancer Subscribers Only Subscribers Only Subscribers Only
10/23/26 Alphamab Oncology (9966) JSKN033 for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
10/23/26 Alphamab Oncology (9966) JSKN033 for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
10/23/26 Alphamab Oncology (9966) JSKN033 for Cervical Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
07/31/2025 Subscribers Only Subscribers Only Regulatory - sNDA/sBLA Filing
07/31/2025 Subscribers Only Subscribers Only Regulatory - IND/CTA Filing
10/28/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
10/31/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
11/11/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update